fbpx
Knowledge is the first and last step to investing

Dr Reddys Laboratories company enters a license agreement with Henlius to commercialize the biosimilar Daratumumab in the US and Europe. Dr Reddy’s Swiss, a subsidiary, will pay up to $ 131.6 Million

Recommended For You

Next Post
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?